European Parliament
Luís Paulo Alves  (S&D ),
in writing.
(PT)
I am voting for this report because we must bear in mind that scientists have discovered an inactive vaccine which does not pose the risks that its predecessor did. It is now generally accepted that inactive vaccines are preferable as the means of controlling and preventing this disease in the European Union.

